A

Aileron Therapeutics
D

ALRN

2.47000
USD
-0.11
(-4.26%)
Market Closed
Volume
1,388
EPS
-2
Div Yield
-
P/E
-1
Market Cap
53,514,874
OverviewSignalsIdeasNews
Related Instruments
    A
    AL
    -0.535
    (-1.09%)
    48.460 USD
    A
    ALG
    1.080
    (0.56%)
    194.300 USD
    A
    ALKS
    -0.150
    (-0.53%)
    28.200 USD
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    A
    ALR
    0.000000
    (0.00%)
    0.000000 USD
    A
    ALRM
    -0.070
    (-0.12%)
    59.850 USD
    A
    ALRS
    -0.080
    (-0.36%)
    22.070 USD
    More
News

Title: Aileron Therapeutics

Sector: Healthcare
Industry: Biotechnology
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development,LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.